Messaging Strategies for COVID-19 Vaccination

(EMPOWeR Trial)

This trial explores how different messages about COVID-19 vaccine options might influence vaccination rates, particularly among those at high risk for severe illness. Researchers aim to determine if highlighting vaccine choices, explaining vaccine mechanisms, or endorsements from healthcare providers can boost vaccine uptake. The trial also examines whether offering choices can increase flu shot rates. It targets Kaiser Permanente Southern California members who haven't received the latest COVID-19 vaccine and have conditions like asthma, diabetes, or heart disease. Participants will receive various reminder messages to assess their effects. As an unphased trial, this study allows participants to contribute to important research that could improve public health messaging strategies.

The trial information does not specify whether you need to stop taking your current medications. It seems focused on vaccine messaging and uptake, so it's unlikely that your current medications will be affected.

Research has shown that COVID-19 vaccines are generally safe and well-tolerated. Independent studies confirm their effectiveness in preventing severe illness and highlight a strong safety record. For instance, mRNA bivalent boosters have been updated to ensure safety and efficacy.

Studies have also explored different communication strategies to improve understanding and acceptance of vaccines. These methods can reduce vaccine hesitancy, which refers to uncertainty about getting vaccinated, and are crucial for increasing vaccination rates.

Researchers are excited about this trial because it tests new ways to encourage COVID-19 vaccination through different messaging strategies. Unlike the standard approach of just sending reminder messages, this trial explores how giving people choices about vaccines, explaining vaccine mechanisms, emphasizing healthcare professional support, and discussing possible side effects might influence their decision to get vaccinated. By tailoring the information to address people's concerns and preferences, these messaging strategies could lead to higher vaccination rates and better public health outcomes. This innovative approach could provide valuable insights into how communication can impact health behaviors.

This trial will explore different messaging strategies to increase COVID-19 vaccination uptake. Research has shown that the way vaccines are discussed can influence vaccination decisions. In this trial, one arm will test the effect of simply informing participants about their vaccine options. Another arm will include explanations about how different vaccines work and provide protection, which can enhance confidence and clarity in decision-making. A separate arm will highlight healthcare personnel's support for multiple vaccine options, fostering trust and encouraging vaccination. Additionally, one arm will address possible side effects to prepare individuals for what to expect after vaccination. These communication strategies aim to increase vaccination by effectively addressing people's concerns and preferences.⁶⁷⁸⁹¹⁰